Human medicines
Avonex
Recall
|
Medicines
|
23/10/2019
The marketing authorisation holder informed its customers on October 22, 2019 that following out-of-specification results during manufacturing below mentioned batches are recalled as a precautionary measure.
Avonex
Read more
Ranitidin Accord
Recall
|
Medicines
|
26/09/2019
The marketing authorisation holder informed its customers on September 26, 2019 that a review of ranitidine medicines after tests showed an impurity called N-nitrosodimethylamine (NDMA).
Ranitidin Accord
Read more
Zantac Brausetabletten
Recall
|
Medicines
|
26/09/2019
The marketing authorisation holder informed its customers on September 26, 2019 that a review of ranitidine medicines after tests showed that "Zantac Brausetabletten" may contain an impurity called N-nitrosodimethylamine (NDMA).
Zantac Brausetabletten
Read more
Ranitidin ratiopharm
Recall
|
Medicines
|
26/09/2019
The marketing authorisation holder informed its customers on September 26, 2019 that a review of ranitidine medicines after tests showed an impurity called N-nitrosodimethylamine (NDMA).
Ranitidin ratiopharm
Read more
Review ranitidine medicines following detection of NDMA
Safety warnings
|
Medicines
|
17/09/2019
Information on NDMA contamination in ranitidine medicines and recalls
Review ranitidine medicines following detection of NDMA
Read more
Ranitidin 1A Pharma, Ranic Hexal
Recall
|
Medicines
|
17/09/2019
The marketing authorisation holder informed its customers on September 16, 2019 that a review of ranitidine medicines after tests showed an impurity called N-nitrosodimethylamine (NDMA).
Ranitidin 1A Pharma, Ranic Hexal
Read more
Zomig 5 mg Nasenspray
Recall
|
Medicines
|
13/09/2019
The marketing authorisation holder informed its customers on September 13, 2019 that below mentioned batch is recalled because of a incorrect package leaflet.
Zomig 5 mg Nasenspray
Read more
Lomaherpan Fieberblasen - Creme
Recall
|
Medicines
|
23/08/2019
The marketing authorisation holder informed its customers on August 23, 2019 that below mentioned batch is recalled because the content of the active substance is below specification limits.
Lomaherpan Fieberblasen - Creme
Read more
Ropinaest
Recall
|
Medicines
|
01/08/2019
The marketing authorisation holder informed its customers on August 1, 2019 that the outer packaging may leak.
Ropinaest
Read more
Elotrace
Recall
|
Medicines
|
03/07/2019
The marketing authorisation holder informed its customers on July 3, 2019 that below mentioned batch of „Elotrace - Infusionszusatz“ show black visible particles.
Elotrace
Read more